Compare Berkshire Hathaway Inc Class B (BRK.B) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Berkshire Hathaway Inc Class B vs HCA Health Inc — how do they compare? Berkshire Hathaway Inc Class B trades at $489.18, while HCA Health Inc trades at $370.07 (market cap $80.66B). The key difference: HCA Health Inc pays a 0.86% dividend while Berkshire Hathaway Inc Class B pays none, and Berkshire Hathaway Inc Class B is trading nearer its 52-week high, HCA Health Inc nearer its low. Which is the better fit depends on your goals.
| BRK.B | HCA | |
|---|---|---|
Sector | Financials | Health |
52-Week High | $513.70 | $545.13 |
52-Week Low | $459.10 | $334.32 |
Market Cap | — | $80.66B |
Enterprise Value | — | $129.57B |
Dividend Yield | — | 0.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BRK.B trades at $488.81, down 1.61% today, with a bullish technical signal from moving averages but neutral oscillators. Support levels are near $487-$494, while resistance sits at $500-$507. Analyst consensus is positive with 57% buy ratings, though key valuation ratios like P/E and P/B are not provided in the snapshot. The stock's technical setup suggests potential for near-term stability if support holds.
The outlook for BRK.B hinges on Berkshire Hathaway's diversified business performance and market sentiment. Risks include economic cycles impacting its holdings, while opportunities lie in its strong cash flow and acquisition strategy. Investors should weigh analyst optimism against broader market volatility.
HCA Healthcare stock trades at $390.74, down 3.9% following a lowered 2026 profit outlook. The company maintains strong fundamentals with revenue growth to $75.6B in 2025 and consistent earnings beats, though technical indicators show bearish momentum. Recent news highlights challenges from payer mix shifts and rising uninsured patients, creating near-term headwinds despite long-term capacity expansion initiatives.
The stock presents a valuation opportunity with a P/E of 13.5x below industry averages, supported by analyst consensus target of $481.80. Key risks include execution on guidance and healthcare reimbursement pressures, but institutional sentiment remains positive with 63% buy ratings, suggesting potential recovery once near-term uncertainties resolve.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Berkshire Hathaway Inc Class B
Berkshire Hathaway is a holding company with diverse subsidiaries, primarily in insurance through Geico and its reinsurance groups. It reinvests profits into various industries, owning Burlington Northern Santa Fe (railroad), Berkshire Hathaway Energy, and major manufacturing, service, and retail businesses like Precision Castparts and Lubrizol. The company operates in a highly decentralized manner.
Read more on BRK.B →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
